To assess the value of CCR2+CD4+ T cells and MCP-1 levels in the longitudinal course, three consecutive therapeutical BALs were analyzed in three patients with PAP (P17, P18, P19) and one patient with cholesterol pneumonitis (P22). The gene discussed is CCL2; the disease is pulmonary alveolar proteinosis.